4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-21-012213
Sr. VP & Chief Medical Officer sold 13,523 shares at an average $86.35 ($1,167,690)
- Sr. VP & Chief Medical Officer acquired 13,523 shares (option exercise)
- Sr. VP & Chief Medical Officer gave up 842 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Adda Nathalie · Sr. VP & Chief Medical Officer
Table I: Non-derivative
10 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-12-01 | Shares withheld for taxes : show line 1 in the form | −842 | $87.68 | $73,827 | 32,902 | D |
| 2021-12-01 | Exercise or conversion : show line 2 in the form | +8,750 | $43.46 | $380,275 | 41,652 | D |
| 2021-12-01 | Exercise or conversion : show line 3 in the form | +4,773 | $48.52 | $231,586 | 46,425 | D |
| 2021-12-01 | Sale : show line 4 in the form | −1,587 | $84.81 | $134,593 | 44,838 | D |
| 2021-12-01 | Sale : show line 5 in the form | −5,736 | $85.49 | $490,371 | 39,102 | D |
| 2021-12-01 | Sale : show line 6 in the form | −2,700 | $86.45 | $233,415 | 36,402 | D |
| 2021-12-01 | Sale : show line 7 in the form | −1,500 | $87.60 | $131,400 | 34,902 | D |
| 2021-12-01 | Sale : show line 8 in the form | −900 | $88.31 | $79,479 | 34,002 | D |
| 2021-12-01 | Sale : show line 9 in the form | −899 | $89.33 | $80,308 | 33,103 | D |
| 2021-12-01 | Sale : show line 10 in the form | −201 | $90.17 | $18,124 | 32,902 | D |
| Open-market sales · 13,523 sh · avg $86.35 · $1,167,690 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-12-01 | Exercise or conversion : show line 11 in the form Stock Option (Right to Buy) | −8,750 | 46,020 | D |
| 2021-12-01 | Exercise or conversion : show line 12 in the form Stock Option (Right to Buy) | −4,773 | 9,180 | D |
Loading xslF345X03/form4.xml…